GAM
EDIT icon

Gotham Asset Management’s Editas Medicine EDIT Stock Holding History

Gotham Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-43,408
Closed -$440K – 1398
2023
Q4 		$440K Buy
+43,408
New +$381K 0.01% 1032

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Gotham Asset Management's EDIT Position: Q1 2024 in Review

Gotham Asset Management sold out of Editas Medicine (EDIT) in Q1 2024, closing a stake of 43,408 shares — an estimated $440K sold.

Gotham Asset Management first reported a position in EDIT in Q4 2023 and held it in 1 quarter. The position peaked at $440K in Q4 2023. 225 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.

  • Gotham Asset Management reported no remaining Editas Medicine position as of Q1 2024 after selling out during the quarter.
  • Gotham Asset Management sold 43,408 Editas Medicine shares in Q1 2024, an estimated $440K.
  • Gotham Asset Management first reported a position in Editas Medicine in Q4 2023 and held it in 1 quarter.
  • Gotham Asset Management's Editas Medicine position peaked at $440K in Q4 2023.
  • 225 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.

Based on Gotham Asset Management's 13F filing for Q1 2024, filed 15 May 2024.